Global Next Generation Sequencing Platform 麻豆原创 Research Report 2024

Publication ID:

PB506248557

Publication Date:

June 18, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Next-generation sequencing (NGS) is a massively parallel sequencing technology that offers ultra-high throughput, scalability, and speed. The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA.
The global Next Generation Sequencing Platform market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Next Generation Sequencing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Next Generation Sequencing Platform is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Next Generation Sequencing Platform in Hospitals and Clinics is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Next Generation Sequencing Platform include Illumina, Thermo Fisher Scientific, Beckman Coulter, Roche Sequencing, Eurofins Scientific, Bio-Rad Laboratories, Beijing Berry Genomics, Helicos and Macrogen, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Next Generation Sequencing Platform, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Sequencing Platform.
Report Scope
The Next Generation Sequencing Platform market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Sequencing Platform market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Sequencing Platform companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Illumina
Thermo Fisher Scientific
Beckman Coulter
Roche Sequencing
Eurofins Scientific
Bio-Rad Laboratories
Beijing Berry Genomics
Helicos
Macrogen
BGI
PerkinElmer
Genewiz
Takara Bio
SciGenom Labs
Novogene
Personalis
Segment by Type
Whole Exome Sequencing
Whole Genome Sequencing
Others
Segment by Application
Hospitals and Clinics
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Sequencing Platform companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Next Generation Sequencing Platform 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Whole Exome Sequencing
1.2.3 Whole Genome Sequencing
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Next Generation Sequencing Platform 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Clinics
1.3.3 Academic & Research Institutes
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Sequencing Platform 麻豆原创 Perspective (2019-2030)
2.2 Next Generation Sequencing Platform Growth Trends by Region
2.2.1 Global Next Generation Sequencing Platform 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Sequencing Platform Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Next Generation Sequencing Platform Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Next Generation Sequencing Platform 麻豆原创 Dynamics
2.3.1 Next Generation Sequencing Platform Industry Trends
2.3.2 Next Generation Sequencing Platform 麻豆原创 Drivers
2.3.3 Next Generation Sequencing Platform 麻豆原创 Challenges
2.3.4 Next Generation Sequencing Platform 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Sequencing Platform Players by Revenue
3.1.1 Global Top Next Generation Sequencing Platform Players by Revenue (2019-2024)
3.1.2 Global Next Generation Sequencing Platform Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Next Generation Sequencing Platform 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Sequencing Platform Revenue
3.4 Global Next Generation Sequencing Platform 麻豆原创 Concentration Ratio
3.4.1 Global Next Generation Sequencing Platform 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Sequencing Platform Revenue in 2023
3.5 Next Generation Sequencing Platform Key Players Head office and Area Served
3.6 Key Players Next Generation Sequencing Platform Product Solution and Service
3.7 Date of Enter into Next Generation Sequencing Platform 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Sequencing Platform Breakdown Data by Type
4.1 Global Next Generation Sequencing Platform Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Next Generation Sequencing Platform Forecasted 麻豆原创 Size by Type (2025-2030)
5 Next Generation Sequencing Platform Breakdown Data by Application
5.1 Global Next Generation Sequencing Platform Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Next Generation Sequencing Platform Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Sequencing Platform 麻豆原创 Size (2019-2030)
6.2 North America Next Generation Sequencing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Sequencing Platform 麻豆原创 Size by Country (2019-2024)
6.4 North America Next Generation Sequencing Platform 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Sequencing Platform 麻豆原创 Size (2019-2030)
7.2 Europe Next Generation Sequencing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Sequencing Platform 麻豆原创 Size by Country (2019-2024)
7.4 Europe Next Generation Sequencing Platform 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Sequencing Platform 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Next Generation Sequencing Platform 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Sequencing Platform 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Sequencing Platform 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Sequencing Platform 麻豆原创 Size (2019-2030)
9.2 Latin America Next Generation Sequencing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Sequencing Platform 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Next Generation Sequencing Platform 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Sequencing Platform 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Next Generation Sequencing Platform 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Sequencing Platform 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Sequencing Platform 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Detail
11.1.2 Illumina Business Overview
11.1.3 Illumina Next Generation Sequencing Platform Introduction
11.1.4 Illumina Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.1.5 Illumina Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Next Generation Sequencing Platform Introduction
11.2.4 Thermo Fisher Scientific Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Next Generation Sequencing Platform Introduction
11.3.4 Beckman Coulter Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.3.5 Beckman Coulter Recent Development
11.4 Roche Sequencing
11.4.1 Roche Sequencing Company Detail
11.4.2 Roche Sequencing Business Overview
11.4.3 Roche Sequencing Next Generation Sequencing Platform Introduction
11.4.4 Roche Sequencing Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.4.5 Roche Sequencing Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Next Generation Sequencing Platform Introduction
11.5.4 Eurofins Scientific Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.5.5 Eurofins Scientific Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Next Generation Sequencing Platform Introduction
11.6.4 Bio-Rad Laboratories Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Beijing Berry Genomics
11.7.1 Beijing Berry Genomics Company Detail
11.7.2 Beijing Berry Genomics Business Overview
11.7.3 Beijing Berry Genomics Next Generation Sequencing Platform Introduction
11.7.4 Beijing Berry Genomics Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.7.5 Beijing Berry Genomics Recent Development
11.8 Helicos
11.8.1 Helicos Company Detail
11.8.2 Helicos Business Overview
11.8.3 Helicos Next Generation Sequencing Platform Introduction
11.8.4 Helicos Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.8.5 Helicos Recent Development
11.9 Macrogen
11.9.1 Macrogen Company Detail
11.9.2 Macrogen Business Overview
11.9.3 Macrogen Next Generation Sequencing Platform Introduction
11.9.4 Macrogen Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.9.5 Macrogen Recent Development
11.10 BGI
11.10.1 BGI Company Detail
11.10.2 BGI Business Overview
11.10.3 BGI Next Generation Sequencing Platform Introduction
11.10.4 BGI Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.10.5 BGI Recent Development
11.11 PerkinElmer
11.11.1 PerkinElmer Company Detail
11.11.2 PerkinElmer Business Overview
11.11.3 PerkinElmer Next Generation Sequencing Platform Introduction
11.11.4 PerkinElmer Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.11.5 PerkinElmer Recent Development
11.12 Genewiz
11.12.1 Genewiz Company Detail
11.12.2 Genewiz Business Overview
11.12.3 Genewiz Next Generation Sequencing Platform Introduction
11.12.4 Genewiz Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.12.5 Genewiz Recent Development
11.13 Takara Bio
11.13.1 Takara Bio Company Detail
11.13.2 Takara Bio Business Overview
11.13.3 Takara Bio Next Generation Sequencing Platform Introduction
11.13.4 Takara Bio Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.13.5 Takara Bio Recent Development
11.14 SciGenom Labs
11.14.1 SciGenom Labs Company Detail
11.14.2 SciGenom Labs Business Overview
11.14.3 SciGenom Labs Next Generation Sequencing Platform Introduction
11.14.4 SciGenom Labs Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.14.5 SciGenom Labs Recent Development
11.15 Novogene
11.15.1 Novogene Company Detail
11.15.2 Novogene Business Overview
11.15.3 Novogene Next Generation Sequencing Platform Introduction
11.15.4 Novogene Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.15.5 Novogene Recent Development
11.16 Personalis
11.16.1 Personalis Company Detail
11.16.2 Personalis Business Overview
11.16.3 Personalis Next Generation Sequencing Platform Introduction
11.16.4 Personalis Revenue in Next Generation Sequencing Platform Business (2019-2024)
11.16.5 Personalis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Illumina
Thermo Fisher Scientific
Beckman Coulter
Roche Sequencing
Eurofins Scientific
Bio-Rad Laboratories
Beijing Berry Genomics
Helicos
Macrogen
BGI
PerkinElmer
Genewiz
Takara Bio
SciGenom Labs
Novogene
Personalis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.